Research shows that 77 percent of lab professionals now use public AI tools alongside their ELN. For many, this is not driven by policy decisions, but by necessity. Governed tools do not yet support ...

A deeper look at unmanaged AI use, also known as "shadow AI", as a response to workflow friction in laboratories.

This article explores the lab AI maturity curve in biopharma R&D, from passive ELNs to active AI-powered systems that ...

Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the ...